Related Experiment Videos
Cyclins and breast cancer.
E A Musgrove1, R Hui, K J Sweeney
1Cancer Biology Division, Garvan Institute of Medical Research, St Vincent's Hospital, Darlinghurst, NSW, Australia.
Journal of Mammary Gland Biology and Neoplasia
|April 1, 1996
Summary
Cyclin D1 is crucial for breast cancer cell growth and is regulated by steroids. Its abnormal expression in breast carcinomas may impact disease progression and response to endocrine therapies.
Area of Science:
- Molecular biology
- Oncology
- Endocrinology
Background:
- Cell cycle control is regulated by cyclins and cyclin-dependent kinases.
- Steroids influence cell proliferation and hormone-dependent cancers.
- Cyclin D1 is a key regulator of the G1 phase in breast cancer cells.
Purpose of the Study:
- To elucidate the role of Cyclin D1 in steroid-mediated proliferation control.
- To understand the implications of Cyclin D1 deregulation in hormone-dependent cancers.
- To investigate the link between Cyclin D1 and breast cancer progression and endocrine therapy response.
Main Methods:
- Analysis of cell cycle regulation by cyclins and cyclin-dependent kinases.
- Investigation of steroid and antagonist regulation of Cyclin D1.
- Examination of Cyclin D1 gene amplification and protein overexpression in breast carcinomas.
Main Results:
- Cyclin D1 is essential, rate-limiting, and sufficient for G1 progression in breast cancer cells.
- Cyclin D1 expression/function is an early response to steroid/antagonist regulation of proliferation.
- The Cyclin D1 gene is amplified in ~15% and overexpressed in 40-50% of primary breast carcinomas.
Conclusions:
- Cyclin D1 plays a significant role in cell cycle control within breast epithelial cells.
- Deregulated Cyclin D1 expression may influence breast cancer progression and phenotype.
- Altered Cyclin D1 levels could affect patient sensitivity to endocrine therapies.